Consensus-driven target product profiles for curative sickle cell disease gene therapies.
Bukini D, Makani J, McCune J, Lee D, Bansbach C, De Vita S, Kemps D, Amin E, Spector J, Tisdale J.
Bukini D, et al. Among authors: amin e.
Mol Ther Methods Clin Dev. 2024 Jun 22;32(3):101287. doi: 10.1016/j.omtm.2024.101287. eCollection 2024 Sep 12.
Mol Ther Methods Clin Dev. 2024.
PMID: 39104574
Free PMC article.
Review.